TriVest

Trium Investements (Pty) Ltd

TriVest is a leading provider of equity for growth capital financings, middle market corporate acquisitions and recapitalizations. Since its founding, TriVest has experienced a huge demand for capital in the early stage sector in Southern Africa, where innovative early-stage and start-up companies often lack the financial, managerial and network resources for expansion and growth.

TriVest prefers to invest in quality small to medium sized companies, which possess or promise strong and defendable market positions in growing or fragmented industries. TriVest always co-invests with company management and pursues transactions which are supported by the management and Boards of Directors of the investee companies.

We also aim to become the preferred sponsor of small to middle market acquisitions. Our mission is to build a track-record of proven closing capabilities and the ability to successfully grow acquired businesses in concert with management.

TriVest pursues investment opportunities which are based in South Africa, but with the potential to achieve scale through expansion within Africa.

We support our portfolio companies via three pillars: funding, resources and networks, thereby becoming a core strategic growth partner to them.

TriVest prefers to invest in the following industries:

  • Healthcare (including Biotechnology)
  • Renewable Energies
  • Security

We select businesses whose market position is strong and can be protected from new or unexpected competition. The firm has particular interest in acquiring companies in fragmented industries. Successful acquisition and growth financing candidates usually possess the following characteristics:

  • Talented and committed management team
  • Strong and defendable market positions
  • Scalability
  • A product line with extended life cycles and low obsolescence risk
  • Sustainable and above average operating profit margins (>25% in Retail and Manufacturing, >50% in Services)

Overview

Website Visit website
Location 158 Jan Smuts Avenue, Rosebank, Johannesburg, 2193, South Africa
Targets South Africa
Sectors Biotechnology and medical research, Healthcare, Insurance, Renewable energy

Activity